Dirk Rades, Cornelia Setter, Olav Dahl, Steven E. Schild and Frank Noack The prognostic impact of tumor cell expression of estrogen receptor-α, progesterone receptor, and androgen receptor in patients irradiated for nonsmall cell lung cancer Cancer 118
Version of Record online: 28 JUN 2011 | DOI: 10.1002/cncr.26282
Tumor cell expression of estrogen receptor-α, progesterone receptor (PR), and androgen receptor (AR) was evaluated in patients who received radiotherapy for stage II/III non-small cell lung cancer with respect to locoregional control, metastases-free survival, and overall survival. Expression of PR and AR was not found to be associated with outcomes.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field